Long-term phenotypic correction of rodent hemiparkinsonism by gene therapy using genetically modified myoblasts
- 24 February 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (5) , 445-449
- https://doi.org/10.1038/sj.gt.3301096
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 30 references indexed in Scilit:
- Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's diseaseMovement Disorders, 1998
- Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cellsProceedings of the National Academy of Sciences, 1998
- High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremorAnnals of Neurology, 1997
- Bipotent progenitor cell lines from the human CNSNature Biotechnology, 1997
- Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1‐year results of a pilot studyAnnals of Neurology, 1996
- Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene.Proceedings of the National Academy of Sciences, 1996
- Isolation, Characterization, and use of Stem Cells from the CNSAnnual Review of Neuroscience, 1995
- Neural-Targeted Gene Therapy for Rodent and Primate HemiparkinsonismExperimental Neurology, 1994
- Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.Proceedings of the National Academy of Sciences, 1989
- Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPAPharmacology Biochemistry and Behavior, 1980